Notícias e Atividades da ReCor Medical

ReCor Medical pertence à Otsuka Holdings.

Otsuka Holdings é uma das ...

• Forbes Global 2000 (#799);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Otsuka Holdings é uma empresa listada sob o símbolo 4578 (JP).

Otsuka Holdings tem presença direta em 10 países.

Otsuka Holdings possui 25 subsidiárias incluindo Astex, Astex Pharmaceuticals e Cambridge Isotope Laboratories.

Eles estão dentro:

• Farmacêutica54%
• Equipamentos Médicos27%
• Outro19%

Veja o organograma con seus 14 executivos principais

Biografias mais buscadas da ReCor Medical

• Lara Barghout, President and Chief Executive Officer
• Kazumichi Kobayashi, Director
• Noriko Tojo, Chairman of the Board

Criar um alerta
para seguir os movimentos de executivos da ReCor Medical.

Otsuka Holdings possui 1.021 concorrentes concorrentes Philips (Holanda), Thermo Fisher Scientific (Estados Unidos) e Medtronic (Irlanda).

Popular M&A news in Equipamentos Médicos

• RadNet has announced the acquisition of Icad  (publicado em 25 de abril de 2025).
• Patient Square Capital adquiriu Patterson Cos (publicado em 22 de abril de 2025).
• Globus Medical has announced the acquisition of Nevro  (publicado em 4 de abril de 2025).

Outros contatos sugeridos na indústria do Equipamentos Médicos

• Christian Pawlu - Head of Corporate Development da Fresenius SE
• Volker Wetekam - Director da Elekta Instrument
• Marc Casper - Chairman of the Board, President and Chief Executive Officer da Thermo Fisher Scientific

Saiba mais sobre a indústria do Equipamentos Médicos

Últimos comunicados de imprensa de ReCor Medical

• Press Releases - Recor Medical
• Have high blood pressure? New procedure could treat hypertension for life
• ReCor Medical Announces Consistent Reduction of Blood Pressure in Pooled Analysis of Three Clinical Trials at AHA 2022 - Recor Medical
• Press Releases - Recor Medical
• GDPR Cookie Compliance (CCPA, DSGVO, Cookie Consent)
• News & Events – Page 4
• ReCor Medical Announces Consistent Reduction of Blood Pressure in Pooled Analysis of Three Clinical Trials at AHA 2022
• News & Events – Page 3
• ReCor Medical Announces Results from Landmark RADIANCE-HTN TRIO Study, Showing Clinically Significant Blood Pressure Reduction with the Paradise Ultrasound RDN System in Patients with Resistant Hypertension
• News & Events
• View more press releases Close

Redes sociais sobre ReCor Medical

• ReCor Medical na Wikipedia, Google News e Yahoo Finance
• ReCor Medical na LinkedIn, Twitter e YouTube